The United States Pharmacopeial Convention, Inc. USP <711> Dissolution. In: USP-NF. 2011. https://doi.org/10.31003/USPNF_M99470_03_01.

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Note for evaluation and recommendation of pharmacopoeial texts for use in the ICH regions on dissolution test – general chapter, Q4B Annex 7 (R2). In: ICH Harmonized Tripartite Guideline. 2010. https://database.ich.org/sites/default/files/Q4B%20Annex%207%20%28R2%29%20Guideline.pdf. Accessed 24 Jun 2025.

USFDA. Guidance for Industry - Dissolution Testing of Immediate Release Solid Oral Dosage Forms. FDA. 1997. https://www.fda.gov/media/70936/download. Accessed 27 Jan 2025.

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances, Q6A. In: ICH Harmonized Tripartite Guideline. 2000. https://database.ich.org/sites/default/files/Q6A%20Guideline.pdf. Accessed 24 Jun 2025.

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Pharmaceutical Development, Q8 (R2). In: ICH Harmonized Tripartite Guideline. 2009. https://database.ich.org/sites/default/files/Q8_R2_Guideline.pdf. Accessed 24 Jun 2025.

Hermans A, Abend AM, Kesisoglou F, Flanagan T, Cohen MJ, Diaz DA, Mao Y, Zhang L, Webster GK, Lin Y, Hahn DA, Coutant CA, Grady H. Approaches for establishing clinically relevant dissolution specifications for immediate release solid oral dosage forms. AAPS J. 2017;19(6):1537–49. https://doi.org/10.1208/s12248-017-0117-1.

Article  CAS  PubMed  Google Scholar 

Markl D, Warman M, Dumarey M, Bergman E-L, Folestad S, Shi Z, Manley LF, Goodwin DJ, Zeitler JA. Review of real-time release testing of pharmaceutical tablets: state-of-the-art, challenges and future perspective. Int J Pharm. 2020;582:119353. https://doi.org/10.1016/j.ijpharm.2020.119353.

Article  CAS  PubMed  Google Scholar 

Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc. 1897;19(12):930–4. https://doi.org/10.1021/ja02086a00.

Article  Google Scholar 

Dokoumetzidis A, Macheras P. A century of dissolution research: from Noyes and Whitney to the Biopharmaceutics Classification System. Int J Pharm. 2006;321(1–2):1–11. https://doi.org/10.1016/j.ijpharm.2006.07.011.

Article  CAS  PubMed  Google Scholar 

Zaborenko N, Shi Z, Corredor CC, et al. First-principles and empirical approaches to predictingin vitro dissolution for pharmaceutical formulation and process development and for product release testing. AAPS J. 2019;21:32. https://doi.org/10.1208/s12248-019-0297-y.

Article  PubMed  Google Scholar 

Sharmista Chatterjee, Considerations for Implementation of RTRT (Real Time Release Testing), IFPAC 2021.

Kakhi M, Li J, Dorantes A. Regulatory experience with continuous manufacturing and real-time release testing for dissolution in new drug applications. J Pharm Sci. 2023;112(10):2604–15. https://doi.org/10.1016/j.xphs.2023.08.004.

Article  CAS  PubMed  Google Scholar 

Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification—the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413–20. https://doi.org/10.1023/a:1016212804288.

Article  CAS  PubMed  Google Scholar 

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. M9: guideline on biopharmaceutics classification system-based biowaivers. In: ICH Harmonized Tripartite Guideline. 2000. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-m9-biopharmaceutics-classification-system-based-biowaivers-step-5_en.pdf. Accessed 24 Jun 2025.

Zaborenko N, Carducci TM, Ryckaert A, Mandula H, Walworth MJ, Smith CJ, Suarez-Sharp S, Dumarey M, Manteiga S, Nielsen S, Altan S, Malsbury A, Nickerson B, Lan Y. Predictive dissolution models for real-time release testing: development and implementation—workshop summary report. Dissolution Technol. 2022;29(3):150–72. https://doi.org/10.14227/DT290322P150.

Article  Google Scholar 

Shi Z, Altan S, Banton D, Nielsen S, Otava M, Garrett A, Walworth MJ. Predictive in-vitro dissolution for real-time release test (RTRT) for continuous manufacturing process on drug product. In: Narang AS, Dubey A, editors. Continuous pharmaceutical processing and process analytical technology. 2023; Chapter 7. CRC Press. https://doi.org/10.1201/9781003149835.

Li H, Pritchard J, Swinney KA. Dissolution modeling for real-time release testing (RTRT). In: Dissolution and translational modeling strategies enabling patient-centric product development; 2017; Baltimore, MD. University of Maryland School of Pharmacy. https://doi.org/10.1201/9781003149835. Accessed 24 Jun 2025.

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Quality Risk Management, Q9. In: ICH Harmonized Tripartite Guidelines. 2006. https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use-ich-guideline-q9-quality-risk-management-step-5-first-version_en.pdf. Accessed 24 Jun 2025.

International Electrotechnical Commission. IEC 60812 Analysis techniques for system reliability – procedure for failure mode and effects (FMEA), Ed3; International standard. 2018. https://webstore.ansi.org/standards/iec/iec60812ed2018. Accessed 24 Jun 2025.

Kleinebudde P, Khinast J, Rantanen J. Continuous manufacturing of pharmaceuticals. 1st ed. New York: Wiley; 2017.

Google Scholar 

Box GE, Hunter JS, Hunter WG. Statistics for experimenters: design, innovation & discovery. 2nd ed. New York: Wiley; 2005.

Google Scholar 

The United States Pharmacopeial Convention, Inc. USP <1092> The Dissolution Procedure: Development and Validation. In: USP-NF. Rockville; 2020. https://doi.org/10.31003/USPNF_M99470_03_01.

USFDA. Compilation of FDA Guidance and Resources for in vitro Dissolution Testing of Immediate Release Solid Oral Dosage Forms. FDA. 2024. https://www.fda.gov/animal-veterinary/new-animal-drug-applications/compilation-fda-guidance-and-resources-in-vitro-dissolution-testing-immediate-release-solid-oral-dosage. Accessed 24 Jun 2025.

Committee for Human Medicinal Products (CHMP), Committee for Veterinary Medicinal Products (CVMP), EMA. Reflection paper on the dissolution specification for generic solid oral immediate release products with systemic action. 2017. https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-dissolution-specification-generic-solid-oral-immediate-release-products-systemic-action-first-version_en.pdf. Accessed 24 Jun 2025.

Agência Nacional de Vigilância Sanitária of Brazil (ANVISA), Ministry of Health, Brazil. Dissolution Guide Applicable to Generic, New and Similar Medicines. Guide No. 14/2018, version 2. 2021. (Portuguese) https://antigo.anvisa.gov.br/documents/10181/3364628/Guia+14_2018_vers%C3%A3o+2_+de+29+10+21.pdf/9cecbb40-217e-4b6e-bf2c-0237641edacb. Accessed 24 Jun 2025.

Abend A, Curran D, Kuiper J, et al. Dissolution testing in drug product development: workshop summary report. AAPS J. 2019;21:21. https://doi.org/10.1208/s12248-018-0288-4.

Article  PubMed  Google Scholar 

Chen H, Wang R, McElderry JD. Discriminative dissolution method development through an aQbD approach. AAPS PharmSciTech. 2023;24:255. https://doi.org/10.1208/s12249-023-02692-8.

Article  CAS  PubMed  Google Scholar 

Committee for Human Medicinal Products (CHMP), Committee for Veterinary Medicinal Products (CVMP), EMA. Addendum to EMA/CHMP/CVMP/QWP/17760/2009 Rev 2: Defining the Scope of an NIRS Procedure. 2014. https://www.ema.europa.eu/en/documents/scientific-guideline/addendum-ema-chmp-cvmp-qwp-17760-2009-rev-3-defining-scope-nirs-procedure_en.pdf. Accessed 24 Jun 2025.

U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Development and Submission of Near Infrared Analytical Procedures Guidance for Industry: USA, 2021. https://www.fda.gov/media/91343/download. Accessed 24 Jun 2025.

Wold S, Sjöström M, Eriksson L. PLS-regression: a basic tool of chemometrics. Chemom Intell Lab Syst. 2001;58:109–30. https://doi.org/10.1016/S0169-7439(01)00155-1.

Article  CAS  Google Scholar 

Goh WY, Lim CP, Pen KK, Subari K. Application of recurrent neural network to prediction of drug dissolution profiles. Neural Comput & Applic. 2002;10:311–7. https://doi.org/10.1007/s005210200003.

Article  Google Scholar 

ICH Quality Implementation Working Group. ICH Quality IWG Points to consider for ICH Q8/Q9/Q10 guidelines. 2011. https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use-ich-quality-implementation-working-group-points-consider-ich-q8q9q10-guidelines_en.pdf. Accessed 24 Jun 2025.

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Validation of Analytical Procedures: Text and Methodology Q2(R1). In: ICH Harmonized Tripartite Guideline. 2005. https://database.ich.org/sites/default/files/Q2%28R1%29%20Guideline.pdf. Accessed 24 Jun 2025.

Altan S, Banton D, Coppenolle H, Kovarik M, Otava M, Schmidt C, A Bayesian approach to Multivariate conditional Regression Surrogate Modelling with Application to Real Time Release Testing in Case studies in Bayesian Methods for Biopharmaceutical testings, Chapman and Hall CRC, first edition, 2022. https://www.taylorfrancis.com/chapters/edit/10.1201/9781003255093-9/bayesian-approach-multivariate-conditional-regression-surrogate-modeling-application-real-time-release-testing-stan-altan-dwaine-banton-hans-coppenolle-martin-kovarik-martin-otava-christ. Accessed 24 Jun 2025.

De Los Santos P, Hofer J, Jayjock E, Kramer T, Lief K, Otava M. Sampling Considerations in Continuous Manufacturing. Pharm Eng. May/June 2019. https://ispe.org/sites/default/files/attachments/public/PE_MayJun19_CompleteIssue_v7_LR_0.pdf. 

Committee for Medicinal Products for Human Use (CHMP), EMA. Guideline on Real Time Release Testing (formerly Guideline on Parametric Release). 2012. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-real-time-release-testing-formerly-guideline-parametric-release-revision-1_en.pdf. Accessed 24 Jun 2025.

PAT & LCS Community of Practice, International Society for Pharmaceutical Engineering (ISPE). Control Strategy Maturity Model/ Process Analytical Technology. 2022. https://cop.ispe.org/discussion/control-strategy-maturity-model. Accessed 24 Jun 2025.

International Society for Pharmaceutical Engineering (ISPE). APQ guide: Process Performance & Product Quality Monitoring System (PPQMS). 2022. https://ispe.org/publications/guidance-documents/apq-guide-process-performance-product-quality-monitoring-system-pppqms. Accessed 24 Jun 2025.

U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Veterinary Medicine (CVM). Data Integrity and Compliance with Drug CGMP - Questions and Answers - Guidance for Industry: USA. 2018. https://www.fda.gov/media/119267/download. Accessed 24 Jun 2025.

Committee for Human Medicinal Products (CHMP), Committee for Veterinary Medicinal Products (CVMP), EMA. Guideline on the use of near infrared spectroscopy by the pharmaceutical industry and the data requirements for new submissions and variations. 2014. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-use-near-infrared-spectroscopy-pharmaceutical-industry-and-data-requirements-new-submissions-and-variations_en.pdf. Accessed 24 Jun 2025.

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Technical and regulatory considerations for pharmaceutical product lifecycle management, Q12. 2019. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-q12-technical-and-regulatory-considerations-pharmaceutical-product-lifecycle-management-step-5_en.pdf. Accessed 24 Jun 2025.